Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (8)

Institute of Science Tokyo: Tokyo, JP

2024-10 to present | Assistant professor (Head and Neck Surgery)
Employment
Source: Self-asserted source
Ryuhei Okada

Tokyo Medical and Dental University: Tokyo, JP

2024-03 to 2024-09 | Assistant professor (Head and Neck Surgery)
Employment
Source: Self-asserted source
Ryuhei Okada

Tokyo Medical and Dental University: Tokyo, JP

2021-04 to 2024-02 | Specially Appointed Assistant Professor (Head and Neck Surgery)
Employment
Source: Self-asserted source
Ryuhei Okada

National Cancer Institute: Bethesda, MD, US

2018-03-05 to 2021-03 | Postodoctoral Fellow (Visiting) (Molecular Imaging Branch)
Employment
Source: Self-asserted source
Ryuhei Okada

Tokyo Medical and Dental University: Tokyo, JP

2015-11-01 to 2018-02-28 (Head and Neck Surgery)
Employment
Source: Self-asserted source
Ryuhei Okada

Toshiba General Hospital: Tokyo, JP

2015-04-01 to 2015-10-31 (Otolaryngology)
Employment
Source: Self-asserted source
Ryuhei Okada

Musashino Red Cross Hospital: Tokyo, JP

2013-04-01 to 2015-03-31 (Otolaryngology)
Employment
Source: Self-asserted source
Ryuhei Okada

Gunma Prefectural Cancer Center: Ota, JP

2011-04-01 to 2013-03-31 (Head and Neck Surgery)
Employment
Source: Self-asserted source
Ryuhei Okada

Education and qualifications (2)

Tokyo Medical and Dental University: Tokyo, JP

2013-04-01 to 2017-03-31 | Ph.D. (Clinical Anatomy)
Education
Source: Self-asserted source
Ryuhei Okada

Tokyo Medical and Dental University: Tokyo, JP

2003-04-01 to 2009-03-31 | M.D. (Faculty of Medicine)
Education
Source: Self-asserted source
Ryuhei Okada

Works (50 of 52)

Items per page:
Page 1 of 2

Antitumor host immunity enhanced by near‐infrared photoimmunotherapy

Cancer Science
2024-12-12 | Journal article
DOI: 10.1111/cas.16427
Contributors: Hiroshi Fukushima; Aki Furusawa; Ryuhei Okada; Yasuhisa Fujii; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Near‐infrared photoimmunotherapy targeting PD‐L1: Improved efficacy by preconditioning the tumor microenvironment

Cancer Science
2024-07 | Journal article
DOI: 10.1111/cas.16195
Contributors: Fuyuki F. Inagaki; Makoto Kano; Aki Furusawa; Takuya Kato; Ryuhei Okada; Hiroshi Fukushima; Seiichiro Takao; Shuhei Okuyama; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

A Case of Syphilis Suspected Preoperatively as a Case of Tongue Cancer

Case Reports in Otolaryngology
2023-11-02 | Journal article
DOI: 10.1155/2023/9469814
Contributors: Shigeru Kondo; Ryuhei Okada; Yosuke Ariizumi; Takashi Kurita; Hiroshi Shintaku; Takahiro Asakage; Rong-San Jiang
Source: check_circle
Crossref

Post-intubation laryngeal injury after COVID-19 treatment causing dyspnea: A report of six cases

Auris Nasus Larynx
2023-10 | Journal article
DOI: 10.1016/j.anl.2022.12.007
Contributors: Naoyuki Sakihama; Ryuhei Okada; Naoto Takahashi; Naoki Fushimi; Tomoki Ooka; Hiroaki Kawabe; Yosuke Ariizumi; Kazuchika Ohno; Yutaka Ueki; Niro Tayama et al.
Source: check_circle
Crossref

Data from Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.c.6550386
Contributors: Yasuhiro Maruoka; Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Daiki Fujimura; Hiroaki Wakiyama; Takuya Kato; Tadanobu Nagaya; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Data from Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.c.6550386.v1
Contributors: Yasuhiro Maruoka; Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Daiki Fujimura; Hiroaki Wakiyama; Takuya Kato; Tadanobu Nagaya; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Data from Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.c.6551037.v1
Contributors: Hiroaki Wakiyama; Takuya Kato; Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Hideyuki Furumoto; Hiroshi Fukushima; Shuhei Okuyama; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Data from Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.c.6551037
Contributors: Hiroaki Wakiyama; Takuya Kato; Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Hideyuki Furumoto; Hiroshi Fukushima; Shuhei Okuyama; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Supplementary Figure from Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22545795.v1
Contributors: Hiroaki Wakiyama; Takuya Kato; Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Hideyuki Furumoto; Hiroshi Fukushima; Shuhei Okuyama; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Supplementary Figure from Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22545795
Contributors: Hiroaki Wakiyama; Takuya Kato; Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Hideyuki Furumoto; Hiroshi Fukushima; Shuhei Okuyama; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Supplementary Figures from Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22543734
Contributors: Yasuhiro Maruoka; Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Daiki Fujimura; Hiroaki Wakiyama; Takuya Kato; Tadanobu Nagaya; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Supplementary Figures from Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22543734.v1
Contributors: Yasuhiro Maruoka; Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Daiki Fujimura; Hiroaki Wakiyama; Takuya Kato; Tadanobu Nagaya; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Data from Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.c.6543850.v1
Contributors: Takuya Kato; Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Hiroaki Wakiyama; Hideyuki Furumoto; Hiroshi Fukushima; Shuhei Okuyama; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Data from Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.c.6543850
Contributors: Takuya Kato; Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Hiroaki Wakiyama; Hideyuki Furumoto; Hiroshi Fukushima; Shuhei Okuyama; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Data from Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.c.6542778.v1
Contributors: Takuya Kato; Ryuhei Okada; Aki Furusawa; Fuyuki Inagaki; Hiroaki Wakiyama; Hideyuki Furumoto; Shuhei Okuyama; Hiroshi Fukushima; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Data from Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.c.6542778
Contributors: Takuya Kato; Ryuhei Okada; Aki Furusawa; Fuyuki Inagaki; Hiroaki Wakiyama; Hideyuki Furumoto; Shuhei Okuyama; Hiroshi Fukushima; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Data from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.c.6542569
Contributors: Zeliang Zheng; Ryuhei Okada; Hisataka Kobayashi; Tadanobu Nagaya; Junxia Wei; Qi Zhou; Fred Lee; Tapan K. Bera; Yun Gao; William Kuhlman et al.
Source: check_circle
Crossref

Data from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.c.6542569.v1
Contributors: Zeliang Zheng; Ryuhei Okada; Hisataka Kobayashi; Tadanobu Nagaya; Junxia Wei; Qi Zhou; Fred Lee; Tapan K. Bera; Yun Gao; William Kuhlman et al.
Source: check_circle
Crossref

Figure S1 from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22519552
Contributors: Zeliang Zheng; Ryuhei Okada; Hisataka Kobayashi; Tadanobu Nagaya; Junxia Wei; Qi Zhou; Fred Lee; Tapan K. Bera; Yun Gao; William Kuhlman et al.
Source: check_circle
Crossref

Figure S1 from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22519552.v1
Contributors: Zeliang Zheng; Ryuhei Okada; Hisataka Kobayashi; Tadanobu Nagaya; Junxia Wei; Qi Zhou; Fred Lee; Tapan K. Bera; Yun Gao; William Kuhlman et al.
Source: check_circle
Crossref

Figure S2 from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22519549
Contributors: Zeliang Zheng; Ryuhei Okada; Hisataka Kobayashi; Tadanobu Nagaya; Junxia Wei; Qi Zhou; Fred Lee; Tapan K. Bera; Yun Gao; William Kuhlman et al.
Source: check_circle
Crossref

Figure S2 from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22519549.v1
Contributors: Zeliang Zheng; Ryuhei Okada; Hisataka Kobayashi; Tadanobu Nagaya; Junxia Wei; Qi Zhou; Fred Lee; Tapan K. Bera; Yun Gao; William Kuhlman et al.
Source: check_circle
Crossref

Figure S3 from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22519546
Contributors: Zeliang Zheng; Ryuhei Okada; Hisataka Kobayashi; Tadanobu Nagaya; Junxia Wei; Qi Zhou; Fred Lee; Tapan K. Bera; Yun Gao; William Kuhlman et al.
Source: check_circle
Crossref

Figure S3 from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22519546.v1
Contributors: Zeliang Zheng; Ryuhei Okada; Hisataka Kobayashi; Tadanobu Nagaya; Junxia Wei; Qi Zhou; Fred Lee; Tapan K. Bera; Yun Gao; William Kuhlman et al.
Source: check_circle
Crossref

Figure S4 from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22519543
Contributors: Zeliang Zheng; Ryuhei Okada; Hisataka Kobayashi; Tadanobu Nagaya; Junxia Wei; Qi Zhou; Fred Lee; Tapan K. Bera; Yun Gao; William Kuhlman et al.
Source: check_circle
Crossref

Figure S4 from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22519543.v1
Contributors: Zeliang Zheng; Ryuhei Okada; Hisataka Kobayashi; Tadanobu Nagaya; Junxia Wei; Qi Zhou; Fred Lee; Tapan K. Bera; Yun Gao; William Kuhlman et al.
Source: check_circle
Crossref

Figure S5 from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22519540
Contributors: Zeliang Zheng; Ryuhei Okada; Hisataka Kobayashi; Tadanobu Nagaya; Junxia Wei; Qi Zhou; Fred Lee; Tapan K. Bera; Yun Gao; William Kuhlman et al.
Source: check_circle
Crossref

Figure S5 from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22519540.v1
Contributors: Zeliang Zheng; Ryuhei Okada; Hisataka Kobayashi; Tadanobu Nagaya; Junxia Wei; Qi Zhou; Fred Lee; Tapan K. Bera; Yun Gao; William Kuhlman et al.
Source: check_circle
Crossref

Figure S6 from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22519537
Contributors: Zeliang Zheng; Ryuhei Okada; Hisataka Kobayashi; Tadanobu Nagaya; Junxia Wei; Qi Zhou; Fred Lee; Tapan K. Bera; Yun Gao; William Kuhlman et al.
Source: check_circle
Crossref

Figure S6 from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22519537.v1
Contributors: Zeliang Zheng; Ryuhei Okada; Hisataka Kobayashi; Tadanobu Nagaya; Junxia Wei; Qi Zhou; Fred Lee; Tapan K. Bera; Yun Gao; William Kuhlman et al.
Source: check_circle
Crossref

Supplementary figures from Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22520790
Contributors: Takuya Kato; Ryuhei Okada; Aki Furusawa; Fuyuki Inagaki; Hiroaki Wakiyama; Hideyuki Furumoto; Shuhei Okuyama; Hiroshi Fukushima; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Supplementary figures from Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22520790.v1
Contributors: Takuya Kato; Ryuhei Okada; Aki Furusawa; Fuyuki Inagaki; Hiroaki Wakiyama; Hideyuki Furumoto; Shuhei Okuyama; Hiroshi Fukushima; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Supplementary figures S1-S10 from Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22523620
Contributors: Takuya Kato; Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Hiroaki Wakiyama; Hideyuki Furumoto; Hiroshi Fukushima; Shuhei Okuyama; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Supplementary figures S1-S10 from Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22523620.v1
Contributors: Takuya Kato; Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Hiroaki Wakiyama; Hideyuki Furumoto; Hiroshi Fukushima; Shuhei Okuyama; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Data from Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.c.6513648
Contributors: Yutaka Kurebayashi; Colleen P. Olkowski; Kelly C. Lane; Olga V. Vasalatiy; Biying C. Xu; Ryuhei Okada; Aki Furusawa; Peter L. Choyke; Hisataka Kobayashi; Noriko Sato
Source: check_circle
Crossref

Data from Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.c.6513648.v1
Contributors: Yutaka Kurebayashi; Colleen P. Olkowski; Kelly C. Lane; Olga V. Vasalatiy; Biying C. Xu; Ryuhei Okada; Aki Furusawa; Peter L. Choyke; Hisataka Kobayashi; Noriko Sato
Source: check_circle
Crossref

Supplementary Data from Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22430577
Contributors: Yutaka Kurebayashi; Colleen P. Olkowski; Kelly C. Lane; Olga V. Vasalatiy; Biying C. Xu; Ryuhei Okada; Aki Furusawa; Peter L. Choyke; Hisataka Kobayashi; Noriko Sato
Source: check_circle
Crossref

Supplementary Data from Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22430577.v1
Contributors: Yutaka Kurebayashi; Colleen P. Olkowski; Kelly C. Lane; Olga V. Vasalatiy; Biying C. Xu; Ryuhei Okada; Aki Furusawa; Peter L. Choyke; Hisataka Kobayashi; Noriko Sato
Source: check_circle
Crossref

Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts

Molecular Cancer Therapeutics
2023-01-03 | Journal article
DOI: 10.1158/1535-7163.MCT-22-0313
Contributors: Takuya Kato; Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Hiroaki Wakiyama; Hideyuki Furumoto; Hiroshi Fukushima; Shuhei Okuyama; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy

Cancer Immunology Research
2022-11-02 | Journal article
DOI: 10.1158/2326-6066.CIR-22-0041
Contributors: Hiroaki Wakiyama; Takuya Kato; Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Hideyuki Furumoto; Hiroshi Fukushima; Shuhei Okuyama; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Intercellular adhesion molecule‐1‐targeted near‐infrared photoimmunotherapy of triple‐negative breast cancer

Cancer Science
2022-09 | Journal article
DOI: 10.1111/cas.15466
Contributors: Hiroshi Fukushima; Takuya Kato; Aki Furusawa; Ryuhei Okada; Hiroaki Wakiyama; Hideyuki Furumoto; Shuhei Okuyama; Eisaku Kondo; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models

Molecular Cancer Therapeutics
2021-11-01 | Journal article
DOI: 10.1158/1535-7163.MCT-21-0470
Contributors: Takuya Kato; Ryuhei Okada; Aki Furusawa; Fuyuki Inagaki; Hiroaki Wakiyama; Hideyuki Furumoto; Shuhei Okuyama; Hiroshi Fukushima; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Endoscopic near‐infrared photoimmunotherapy in an orthotopic head and neck cancer model

Cancer Science
2021-08 | Journal article
DOI: 10.1111/cas.15013
Contributors: Ryuhei Okada; Aki Furusawa; Fuyuki Inagaki; Hiroaki Wakiyama; Takuya Kato; Shuhei Okuyama; Hideyuki Furumoto; Hiroshi Fukushima; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression

Cancer Research
2021-06-01 | Journal article
DOI: 10.1158/0008-5472.CAN-20-2673
Contributors: Yutaka Kurebayashi; Colleen P. Olkowski; Kelly C. Lane; Olga V. Vasalatiy; Biying C. Xu; Ryuhei Okada; Aki Furusawa; Peter L. Choyke; Hisataka Kobayashi; Noriko Sato
Source: check_circle
Crossref

Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials

EBioMedicine
2021-05 | Journal article
DOI: 10.1016/j.ebiom.2021.103345
Contributors: Ryuhei Okada; Aki Furusawa; Daniel W. Vermeer; Fuyuki Inagaki; Hiroaki Wakiyama; Takuya Kato; Tadanobu Nagaya; Peter L. Choyke; William C. Spanos; Clint T. Allen et al.
Source: check_circle
Crossref

Quantitative analysis of vascular changes during photoimmunotherapy using speckle variance optical coherence tomography (SV-OCT)

Biomedical Optics Express
2021-04-01 | Journal article
DOI: 10.1364/BOE.419163
Contributors: Shulian Wu; Ryuhei Okada; Yi Liu; Yuhong Fang; Feng Yan; Chen Wang; Hui Li; Hisataka Kobayashi; Yu Chen; Qinggong Tang
Source: check_circle
Crossref

Diagnostic imaging in near‐infrared photoimmunotherapy using a commercially available camera for indocyanine green

Cancer Science
2021-03 | Journal article
DOI: 10.1111/cas.14809
Contributors: Fuyuki F. Inagaki; Daiki Fujimura; Aki Furusawa; Ryuhei Okada; Hiroaki Wakiyama; Takuya Kato; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green

Molecular Pharmaceutics
2021-03-01 | Journal article
DOI: 10.1021/acs.molpharmaceut.0c01107
Contributors: Fuyuki F. Inagaki; Daiki Fujimura; Aki Furusawa; Ryuhei Okada; Hiroaki Wakiyama; Takuya Kato; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref

Increased Immunogenicity of a Minimally Immunogenic Tumor after Cancer-Targeting Near Infrared Photoimmunotherapy

Cancers
2020-12-12 | Journal article
DOI: 10.3390/cancers12123747
Contributors: Hiroaki Wakiyama; Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Takuya Kato; Yasuhiro Maruoka; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models

Cancer Immunology Research
2020-03-01 | Journal article
DOI: 10.1158/2326-6066.CIR-19-0517
Contributors: Yasuhiro Maruoka; Aki Furusawa; Ryuhei Okada; Fuyuki Inagaki; Daiki Fujimura; Hiroaki Wakiyama; Takuya Kato; Tadanobu Nagaya; Peter L. Choyke; Hisataka Kobayashi
Source: check_circle
Crossref
Items per page:
Page 1 of 2
How many people are using ORCID?